Two Hot Stocks Under Limelight: Walt Disney Company (The) (NYSE:DIS), Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)

stock overview

Walt Disney Company (The) (NYSE:DIS)

Walt Disney Company (The) (NYSE:DIS) closed at $109.44 on the last trading session with an decrease of -1.86%, whereas, it previously closed at $111.51. The company has a market capitalization of $163.07 Billion. The company traded shares of 11.09 Million on the trading day while its three month average volume stands at 8.25 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Walt Disney Company (The) (NYSE:DIS) produced diluted EPS of 7.24. The EPS estimate for next year as estimated by analysts is at 7.24 while EPS for next quarter is estimated at 1.63. Earnings per Share growth for this year is reported at 27.1, while the analysts estimated the EPS growth for next year at 7.24% and Earnings growth for next 5 years stands at 3.64% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 16.4%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Walt Disney Company (The) (NYSE:DIS) is at 15.12 while the forward p/e is at 15.11. The P/S or Price to Sales ratio of Walt Disney Company (The) (NYSE:DIS) stands at 2.75 and Price to Book or P/B for the most recent quarter stands at 3.24. The Price to Free Cash Flow ratio or P/FCF is reported at 19.82. The quick ratio and the current ratio of Walt Disney Company (The) (NYSE:DIS) are reported at 0.9 and 1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Walt Disney Company (The) (NYSE:DIS) stands at 11.1, 23 and 16.5 respectively

The trailing twelve month Revenue of Walt Disney Company (The) (NYSE:DIS) is reported at 59.39 Billion with income of 10.86 Billion. The outstanding shares of Walt Disney Company (The) (NYSE:DIS) are 1.49 Billion. The institutional Ownership of the shares of 65.5 stands at 0.80%, this figure is increased 0.81 in the last six months. The insider ownership for the shares of Walt Disney Company (The) (NYSE:DIS) is ticked at 0.1%, the figure is plummeted -6.14% in the last six months.

Some other important financial aspects to be discussed here for Walt Disney Company (The) (NYSE:DIS) is the Mean Target Price estimated by the analysts which stands at 124.7. The 52 week high of Walt Disney Company (The) (NYSE:DIS) is placed at 120.20 and 52 week low is standing at 97.68.

Performance wise the shares of Walt Disney Company (The) (NYSE:DIS) fell down -2.11% for the week, it also fell -2.98% for the monthly performance, while for the quarter it went up -6.5%. The shares decrease -4.13% for the half year and plummeted for the Year-To-Date performance. The shares of Walt Disney Company (The) (NYSE:DIS) grew 7.98% for the yearly performance.

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) closed at $16.92 on the last trading session with an increase of 8.05%, whereas, it previously closed at $15.66. The company has a market capitalization of $1.54 Billion. The company traded shares of 3.69 Million on the trading day while its three month average volume stands at 1.73 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) produced diluted EPS of -0.35. The EPS estimate for next year as estimated by analysts is at -0.31 while EPS for next quarter is estimated at 0.18. Earnings per Share growth for this year is reported at -39.9, while the analysts estimated the EPS growth for next year at -0.31% and Earnings growth for next 5 years stands at 7.33% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 12.9%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) stands at 32.59 and Price to Book or P/B for the most recent quarter stands at 8.95. The Price to Free Cash Flow ratio or P/FCF is reported at 11.52. The quick ratio and the current ratio of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) are reported at 1.8 and 1.8 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) stands at -16.9, -24.1 and -57 respectively

The trailing twelve month Revenue of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is reported at 47.3 Million with income of -29200000. The outstanding shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) are 91.09 Million. The institutional Ownership of the shares of 61.3 stands at 0.80%, this figure is increased 1.69 in the last six months. The insider ownership for the shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is ticked at 4.6%, the figure is plummeted -20.88% in the last six months.

Some other important financial aspects to be discussed here for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is the Mean Target Price estimated by the analysts which stands at 23.3. The 52 week high of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is placed at 22.39 and 52 week low is standing at 4.77.

Performance wise the shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) rose up 17.91% for the week, it also rise 12.8% for the monthly performance, while for the quarter it went down 5.68%. The shares increase 2.48% for the half year and flew up for the Year-To-Date performance. The shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) grew 198.94% for the yearly performance.